scholarly article | Q13442814 |
P356 | DOI | 10.1038/JHH.2010.4 |
P698 | PubMed publication ID | 20147968 |
P50 | author | Allan Linneberg | Q37392821 |
P2093 | author name string | H Ibsen | |
L T Jensen | |||
B Flambard | |||
L Usinger | |||
P2860 | cites work | Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies | Q28036762 |
Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program | Q30468252 | ||
Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension | Q33989282 | ||
Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial | Q34008825 | ||
A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects | Q34172040 | ||
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension | Q34201728 | ||
Dairy food consumption, blood pressure and stroke | Q34297987 | ||
Hypotensive peptides from milk proteins | Q34309622 | ||
Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension | Q34444730 | ||
Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women | Q34470007 | ||
Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement | Q34477935 | ||
Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials | Q34498444 | ||
Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation | Q34610630 | ||
Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials | Q34787114 | ||
Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies | Q34910326 | ||
Anti-hypertensive activity of fermented dairy products containing biogenic peptides | Q34944932 | ||
Does fermented milk possess antihypertensive effect in humans? | Q37456144 | ||
Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats | Q43925527 | ||
Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives | Q44355805 | ||
The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans. | Q45977596 | ||
Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults | Q47233487 | ||
Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. | Q51483001 | ||
Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure | Q73543265 | ||
Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases | Q73616962 | ||
Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats | Q73742481 | ||
P433 | issue | 10 | |
P921 | main subject | hypertension | Q95566669 |
P304 | page(s) | 678-683 | |
P577 | publication date | 2010-02-11 | |
P1433 | published in | Journal of Human Hypertension | Q15746469 |
P1476 | title | The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension | |
P478 | volume | 24 |
Q37976373 | Antihypertensive peptides from food proteins: a review. |
Q35003895 | Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials |
Q35786411 | Dairy Consumption, Blood Pressure, and Risk of Hypertension: An Evidence-Based Review of Recent Literature |
Q36590794 | Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials |
Q37176141 | Effect of Probiotics on Blood Lipid Concentrations: A Meta-Analysis of Randomized Controlled Trials |
Q24200294 | Fermented milk for hypertension |
Q36801785 | Intake of Blueberry Fermented by Lactobacillus plantarum Affects the Gut Microbiota of L-NAME Treated Rats |
Q26851617 | Meeting and exceeding dairy recommendations: effects of dairy consumption on nutrient intakes and risk of chronic disease |
Q27023113 | Milk proteins, peptides, and oligosaccharides: effects against the 21st century disorders |
Q56983123 | Predictors of the short-term effect of isoleucine-proline-proline/valine-proline-proline lactotripeptides from casein on office and ambulatory blood pressure in subjects with pharmacologically untreated high-normal blood pressure or first-degree hype |
Q47151840 | Scientific Opinion on the substantiation of health claims related to isoleucine‐proline‐proline (IPP) and valine‐proline‐proline (VPP) and maintenance of normal blood pressure (ID 661, 1831, 1832, 2891, further assessment) pursuant to Article 13(1... |
Q49557929 | The effects of probiotics on total cholesterol: A meta-analysis of randomized controlled trials |
Search more.